Classic Benjamin Graham Stock Screener
Free Value Investing for Intelligent Investors across Global Equity Markets, as recommended by Warren Buffett.
| Company Name | MIC | HQ | Fiscal Year | Last Updated | Curr Code | Previous Close | Graham Number | Graham Number(%) | NCAV/ NetNet | NCAV/ NetNet(%) | Graham Grade | Intrinsic Value | Intrinsic Value(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 195841 | Mastercard Inc (M4IF.BE) | XBER | US | 2023-12-31 | 1 year ago | USD | 0.00 | 41.41 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 195842 | Berkshire Hathaway Inc (A18Y2C.BE) | XBER | US | 2024-12-31 | 2 weeks ago | USD | 0.00 | 617,066.47 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 195843 | Berkshire Hathaway Inc (A18Y2C.BE) | XBER | US | 2023-12-31 | 1 year ago | USD | 0.00 | 567,099.15 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 195844 | Colgate-Palmolive Co (A3LE1P.BE) | XBER | US | 2024-12-31 | 1 week ago | USD | 0.00 | 4.05 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 195845 | Avalo Therapeutics Inc (US05338F1084.BE) | XBER | US | 2023-12-31 | 9 months ago | USD | 0.00 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 195846 | Avalo Therapeutics Inc (US05338F1084.BE) | XBER | US | 2023-12-31 | 1 year ago | USD | 0.00 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 195847 | Goldman Sachs Group Inc (A3KP1A.BE) | XBER | US | 2024-12-31 | 1 month ago | USD | 0.00 | 524.69 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 195848 | Goldman Sachs Group Inc (A3KP1A.BE) | XBER | US | 2023-12-31 | 1 year ago | USD | 0.00 | 552.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 195849 | Goldman Sachs Group Inc (A3KP1A.BE) | XBER | US | 2023-12-31 | 1 year ago | USD | 0.00 | 552.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 195850 | Sempra (SE4A.BE) | XBER | US | 2023-12-31 | 1 year ago | USD | 96.07 | 58.67 | 61.07% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |